Pharma’s climate change vulnerability and opportunity
pharmaphorum
SEPTEMBER 9, 2022
In 2019, the pharmaceutical industry produced 48.55 As a critical industry, any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the industry and health ramifications for the global population”. Vulnerability . Making plans is not enough.
86 
Let's personalize your content